Dr. Rubin specializes in the treatment and assessment of digestive diseases.
His clinical expertise includes treating inflammatory bowel disease, such as ulcerative colitis and Crohn’s disease. Dr. Rubin’s clinical research includes outcomes of IBD treatment, prevention of gastrointestinal cancer and new therapies for IBD.
He is a member of the American College of Gastroenterology, the Crohns and Colitis Foundation of America and the American Gastroenterology Association.
More articles on gastroenterology:
5 must-read articles for GI physicians this week: November 29-December 5
To research insurance benefits or have a colonoscopy? You pick
Takeda earns shareholder approval for $58B Shire acquisition — 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.